Place of cancer among the risk factors in venous thromboembolism;Place du cancer parmi les facteurs de risque de la maladie thromboembolique veineuse

Pathologie Biologie

Volumn 56, Issue 4, 2008, Pages 178-183

  Descourt, R ^a   Righini, M ^b   Carrier, M ^c   Le Gal, G ^a  

^a Universite de Brest   (France)

^b Hôpital Universitaire HUG   (Switzerland)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Neoplasms; Risk factors; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ANTICOAGULATION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CAUSE OF DEATH; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; MORTALITY; NEOPLASM; OUTCOME ASSESSMENT; PROGNOSIS; RECURRENT DISEASE; REVIEW; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TUMOR LOCALIZATION; VENOUS THROMBOEMBOLISM;

FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; PROGNOSIS; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 44549088867     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2007.12.008     Document Type: Review

References (25)

1. Heit J.A., Silverstein M.D., Mohr D.N., Petterson T.M., O'Fallon W.M., and Melton L.J.J.3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160 6 (2000) 809-815
2. Blom J.W., Doggen C.J., Osanto S., and Rosendaal F.R. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293 6 (2005) 715-722
3. Samama M.M. An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius Study. Arch Intern Med 160 22 (2000) 3415-3420
4. Noboa S., Mottier D., and Oger E. Estimation of a potentially preventable fraction of venous thromboembolism: a community-based prospective study. J Thromb Haemost 4 12 (2006) 2720-2722
5. Heit J.A., O'Fallon W.M., Petterson T.M., Lohse C.M., Silverstein M.D., Mohr D.N., et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 162 11 (2002) 1245-1248
6. Chew H.K., Wun T., Harvey D., Zhou H., and White R.H. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 166 4 (2006) 458-464
7. Alikhan R., Cohen A.T., Combe S., Samama M.M., Desjardins L., Eldor A., et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med 164 9 (2004) 963-968
8. White R.H., Zhou H., and Romano P.S. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. J Thromb Haemost 90 3 (2003) 446-455
9. Le Gal G., Righini M., Roy P.M., Meyer G., Aujesky D., Perrier A., et al. Differential value of risk factors and clinical signs for diagnosing pulmonary embolism according to age. J Thromb Haemost 3 (2005) 2457-2464
10. Le Gal G., Righini M., Roy P.-M., Sanchez O., Aujesky D., Bounameaux H., et al. Prediction of pulmonary embolism in the emergency department: the revised geneva score. Ann Intern Med 144 3 (2006) 165-171
11. Wells P.S., Anderson D.R., Rodger M., Ginsberg J.S., Kearon C., Gent M., et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. J Thromb Haemost 83 3 (2000) 416-420
12. Blom J.W., Osanto S., and Rosendaal F.R. The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost 2 10 (2004) 1760-1765
13. Heit J.A. Cancer and venous thromboembolism: scope of the problem. Cancer Control 12 Suppl 1 (2005) 5-10
14. Thodiyil P.A., and Kakkar A.K. Variation in relative risk of venous thromboembolism in different cancers. J Thromb Haemost 87 6 (2002) 1076-1077
15. Lee A.Y. Epidemiology and management of venous thromboembolism in patients with cancer. Thromb Res 110 4 (2003) 167-172
16. Shen V.S., and Pollak E.W. Fatal pulmonary embolism in cancer patients: is heparin prophylaxis justified?. South Med J 73 7 (1980) 841-843
17. Khorana A.A., Francis C.W., Culakova E., Fisher R.I., Kuderer N.M., and Lyman G.H. Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 24 3 (2006) 484-490
18. Khorana A.A., Francis C.W., Culakova E., Kuderer N.M., and Lyman G.H. Increasing rate of venous thromboembolism among hospitalized cancer patients. J Thromb Haemost (2007) (Suppl):OT-001
19. Pihusch R., Danzl G., Scholz M., Harich D., Pihusch M., Lohse P., et al. Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma. Cancer 94 12 (2002) 3120-3126
20. Ambrus J.L., Ambrus C.M., Mink I.B., and Pickren J.W. Causes of death in cancer patients. J Med 6 1 (1975) 61-64
21. Sorensen H.T., Mellemkjaer L., Olsen J.H., and Baron J.A. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343 25 (2000) 1846-1850
22. Heit J.A., Silverstein M.D., Mohr D.N., Petterson T.M., O'Fallon W.M., and Melton III L.J. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 159 5 (1999) 445-453
23. Prandoni P., Lensing A.W., Piccioli A., Bernardi E., Simioni P., Girolami B., et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100 (2002) 3484-3488
24. Heit J.A., Mohr D.N., Silverstein M.D., Petterson T.M., O'Fallon W.M., and Melton III L.J. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 160 6 (2000) 761-768
25. Descourt R., Le Gal G., Couturaud F., Mottier D., Bressollette L., Robinet G., et al. Recurrent venous thromboembolism under anticoagulant therapy: a high risk in adenocarcinoma?. J Thromb Haemost 95 5 (2006) 912-913